Magnetic Resonance-Guided Focused Ultrasound Versus Conventional Radiation Therapy for Painful Bone Metastasis

2017 ◽  
Vol 99A (18) ◽  
pp. 1572-1578 ◽  
Author(s):  
Hsin-Lun Lee ◽  
Chia-Chun Kuo ◽  
Jo-Ting Tsai ◽  
Chun-You Chen ◽  
Meng-Huang Wu ◽  
...  
2021 ◽  
pp. 1-4
Author(s):  
Paolo Farace ◽  
Stefano Tamburin

Amyloid-β deposition is one of the neuropathological hallmarks of Alzheimer’s disease (AD), but pharmacological strategies toward its reduction are poorly effective. Preclinical studies indicate that low-dose radiation therapy (LD-RT) may reduce brain amyloid-β. Animal models and proof-of-concept preliminary data in humans have shown that magnetic resonance guided focused ultrasound (MRgFUS) can reversibly open the blood-brain-barrier and facilitate the delivery of targeted therapeutics to the hippocampus, to reduce amyloid-β and promote neurogenesis in AD. Ongoing clinical trials on AD are exploring whole-brain LD-RT, which may damage radio-sensitive structures, i.e., hippocampus and white matter, thus contributing to reduced neurogenesis and radiation-induced cognitive decline. However, selective irradiation of cortical amyloid-β plaques through advanced LD-RT techniques might spare the hippocampus and white matter. We propose combined use of advanced LD-RT and targeted drug delivery through MRgFUS for future clinical trials to reduce amyloid-β deposition in AD since its preclinical stages.


2019 ◽  
Vol 103 (5) ◽  
pp. E39-E40
Author(s):  
Sonal S. Noticewala ◽  
Daniel R. Gomez ◽  
Chad Tang ◽  
Laurence D. Rhines ◽  
Claudio E. Tatsui ◽  
...  

2019 ◽  
Vol 59 (2) ◽  
pp. 164-170
Author(s):  
Michelle Iocolano ◽  
Aaron T. Wild ◽  
Margaret Hannum ◽  
Zhigang Zhang ◽  
Charles B. Simone ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document